Eisai Co., Ltd.
Eisai Long-Term Vision and 3-Year Plan Progress ｜ May 2026
Eisai reports on the progress of its long-term vision and 3-year plan, focusing on business growth and strategic enhancement. The company is expanding its pharmaceutical business and promoting new ventures toward achieving its 2026 goals.
Key Figures
- Sales Revenue: Unknown
- Core Operating Income: Unknown
- Target Sales for FY2028: Maintaining around 250 billion yen
AI要約
Initiatives Toward Strategic Goals and Achievement
Eisai is strengthening its pharmaceutical research and development and global expansion, with a particular focus on oncology and nervous system disorders. It aims to promote new drug discovery and the global deployment of existing drugs, targeting maintaining sales at around 250 billion yen in FY2028. Additionally, the company is leveraging digital technology and open innovation to pursue sustainable growth and increase corporate value.
Eisai Co., Ltd.
Company overview · Stock price · Financial data · All IR
